Delivery Order SPE2DB24D2105-SPE2DB24FANVS
- Not listed
- This federal contract award, valued at $1,688.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4559754687 TOVIAZ ER 8 MG TABLET 30S, with a completion date of January 30, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,178.49, is for the delivery of a pharmaceutical product, specifically 4560937530 - TOVIAZ ER 8 MG TABLET 30S. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of May 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of TOVIAZ ER 4 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $2,339.99 and is a firm-fixed-price delivery order. The award date is August 22, 2024, and the ultimate completion date is August 23, 2024. This contract is not set aside for any specific business type. AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,313.70, is for the supply of the medication TOVIAZ ER 8 MG TABLET 30S. The contract has a firm-fixed price pricing type and runs through May 31, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,161.25 firm fixed-price delivery order is for the supply of Toviaz ER 8 mg tablets, a prescription medication, to support military healthcare programs. The contract has a performance period through May 5, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D1004) under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $1,817.58. The contract is for the delivery of TOVIAZ ER 4 MG TABLET 30S, a pharmaceutical product, with a completion date of October 9, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,425.69 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TOVIAZ ER 4 MG TABLET 30S. This award is part of a larger DLA Troop Support Medical program to supply pharmaceuticals and medical supplies to military treatment facilities. AmerisourceBergen, a prime contractor, has previously received numerous delivery orders from DLA for a range of pharmaceutical and medical...
- This federal contract award, with the identifier SPE2DB20D2104|SPE2DB25FMHRM, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,553.81, is a Firm Fixed Price Delivery Order for the supply of TOVIAZ ER 4 MG TABLET 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,211.87, is for the delivery of the prescription medication Toviaz ER 8 mg Tablet in packages of 30. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, with the ID SPE2DB24D2011|SPE2DB24FBPPU, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,559.96, is a Firm Fixed Price Delivery Order for the supply of TOVIAZ ER 4 MG TABLET 30S. It has an ultimate completion date of May 1, 2024. The contract is not designated with any set-aside requirements, indicating it was awarded through full and open competition....
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB24FANVSDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,763.99 firm-fixed-price delivery order is for the pharmaceutical product TOVIAZ ER 8 MG TABLET 30S. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as AmerisourceBergen. This extensive contracting relationship demonstrates AmerisourceBergen's critical role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 3/6/24 |